Frank G. Groenewegen
- Shareholder and General Manager of Regis Medical GmbH
- 30 years of working experience in international sales and marketing in the health care sector
- Built several medical device distribution companies including Cardiologic GmbH (sold to Boston Scientific 2002) and OVUM Ventures GmbH ("CoreValve" sold to Medtronic 2009) over the last two decades
- Experienced medical entrepreneur investing in 20+ medical device start-ups
- More than 14 exits including CoreValve, InterVentional Technologies, Embolic Protection, ACIST Medical Systems, MicroVena, Vascular Solutions, A.V.E., Micrus Endovascular, Vascular Science and Endologix
- Various capacities by AHSC American Hospital Supply Corporation (now part of Baxter), W. L. Gore & Associates and St. Jude Medical, Inc.
David P. Thompson
- Shareholder and General Manager of Regis Medical GmbH
- 26 years of working experience in international corporate management and finance, the last 17 years in the health care sector
- Executive board member of two U.S. companies
- U.K. Chartered Accountant (ACA)
- Bachelor of Arts degree in accounting from Birmingham University (UK)
- Built several medical device distribution companies including Cardiologic GmbH (sold to Boston Scientific 2002) and OVUM Ventures GmbH ("CoreValve" sold to Medtronic 2009), over the last two decades
- Experienced medical entrepreneur investing in 10+ medical device start-ups
- Various capacities in London and Munich as trainee accountant through to senior manager at Ernst & Young, focused mainly on M&A transactions